Joel Habener
Joel Habener | |
|---|---|
| Born | Joel Francis Habener June 29, 1937 Indianapolis, Indiana, U.S. |
| Died | December 28, 2025 (aged 88) Newton, Massachusetts, U.S. |
| Awards | Warren Alpert Foundation Prize (2020) Canada Gairdner International Award (2021) VinFuture Prize (2023) Princess of Asturias Award (2024) Tang Prize (2024) Lasker Award (2024) BBVA Foundation Frontiers of Knowledge Award (2024) Breakthrough Prize in Life Sciences (2025) |
| Scientific career | |
| Institutions | Harvard Medical School; Massachusetts General Hospital |
Joel Francis Habener (June 29, 1937 – December 28, 2025) was an American endocrinologist who was professor of medicine at Harvard Medical School and an associate physician at the Massachusetts General Hospital.[1]
Early life and education
Habener graduated with a BS degree Cum Laude from the University of Redlands in 1960. He received his MD in 1965 from the University of California, Los Angeles, School of Medicine.[2]
Career
Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2).[3]
He was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.[4] He was elected to the National Academy of Sciences in 2020.[5] In 2021, he was awarded the Canada Gairdner International Award.[6] In 2023, he received the VinFuture Prize.[7] In 2024, he was awarded the Princess of Asturias Award for Technical and Scientific Research,[8] the Tang Prize in the category of "Biopharmaceutical Science",[9] the Lasker Award for clinical research,[10][11] and the BBVA Foundation Frontiers of Knowledge Award in the category "Biology and Biomedicine".[12] In 2025 he received the Breakthrough Prize in Life Sciences.[13]
Death
Habener died in Newton, Massachusetts, on December 28, 2025, at the age of 88.[14]
References
- ^ "Joel Habener, M.D. | Mass General Research Institute". Find a Researcher - Massachusetts General Hospital. Retrieved January 9, 2025.
- ^ "Joel Habener, MD | Scholars | Harrington Discovery Institute at University Hospitals". www.harringtondiscovery.org. Retrieved January 23, 2025.
- ^ Ardehali, Hossein (September 26, 2024). "Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1". The Journal of Clinical Investigation. 134 (19). doi:10.1172/JCI186225. ISSN 0021-9738. PMC 11446598.
- ^ "Prize Recipients | Warren Alpert Foundation Prize". warrenalpert.org.
- ^ "2020 NAS Election". www.nasonline.org.
- ^ "Gairdner Awards Laureates". Gairdner Foundation. Retrieved January 10, 2026.
- ^ Nhu, Quynh (December 21, 2023). "Battery researchers win $3M Vietnamese awards". VnExpress.
- ^ "Five world leaders in the field of Endocrinology, Princess of Asturias Award for Technical and Scientific Research". Fundación Princesa de Asturias. May 6, 2024. Retrieved January 10, 2026.
- ^ "Benefiting 1.5 billion Diabetics and Obese Patients Worldwide Tang Prize in Biopharmaceutical Science Honoring Three Scientists". Tang Prize. June 19, 2024. Retrieved January 10, 2026.
- ^ "GLP-1-based therapy for obesity: 2024 Lasker-DeBakey Clinical Medical Research Award". Lasker Foundation. Retrieved January 10, 2026.
- ^ Prashant Nair (September 19, 2024). "QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award". Proceedings of the National Academy of Sciences of the United States of America. 121 (39). doi:10.1073/PNAS.2416868121. ISSN 0027-8424. PMID 39297682. Wikidata Q130375905.
- ^ "Frontiers of Knowledge Award in Biology and Biomedicine in the seventeenth edition". Frontiers of Knowledge Awards. January 8, 2025. Retrieved January 10, 2026. Habener was honored in the 17th edition of the awards, for the year 2024, although the announcements of winners and the presentation ceremonies took place in 2025.
- ^ "Joel Habener". Breakthrough Prize. Retrieved January 10, 2026.
- ^ "Joel Habener, Whose Research Helped Develop Weight-Loss Drugs, Dies at 88". The Wall Street Journal. December 29, 2025. Retrieved December 29, 2025.